Findings

What do systematic reviews say?

920 questions · 964 findings · 153 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 215 · 22.3%GRADE not reported 85 · 8.8%Very low 241 · 25%Low 260 · 27%Moderate 135 · 14%High 28 · 2.9%

Behavioural activation vs medication

depression symptoms(continuous) up to 6 months (12 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 180 participants
Low

Behavioural activation vs CBT

quality of life (continuous)up to 6 months (8 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 268 participants
Moderate

Behavioural activation vs no treatment

depression symptoms(continuous) up to 6 months (2‐5 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 187 participants
Moderate

Behavioural activation vs no treatment

quality of life (continuous)up to 6 months (2 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 118 participants
High

Behavioural activation vs no treatment

Anxiety · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low

Behavioural activation vs treatment

depression symptoms (continuous) up to 6 months (4‐8 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
15 studies · 2208 participants
Low

Behavioural activation vs treatment

quality of life (continuous)up to 6 months (2 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 1299 participants
Very low

Behavioural activation vs treatment

social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 88 participants
Low

Behavioural activation vs treatment

Anxiety · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1063 participants
Moderate

Behavioural activation vs CBT

social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 111 participants
Very low

Behavioural activation vs CBT

Anxiety · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 646 participants
Moderate

Antidepressants plus benzodiazepines vs antidepressants alone

Depression severity: continuous phase (> 12 weeks) · patients with major depression

1 finding from 1 review

Antidepressants plus benzodiazepines for adults with major depression 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Low

Manual paper reminders added to another QI intervention vs the same QI intervention

Patient outcomes (continuous) · Healthcare professionals

1 finding from 1 review

Manually‐generated reminders delivered on paper: effects on professional practice and patient outcomes 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 946 participants
Moderate

Manual paper reminders vs other quality‐improvement (QI) interventions

Changes in professional practice (continuous) · Healthcare professionals

The review found no eligible studies for this question.

1 finding from 1 review

Manually‐generated reminders delivered on paper: effects on professional practice and patient outcomes 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Manual paper reminders vs other quality‐improvement (QI) interventions

Patient outcomes (continuous) · Healthcare professionals

The review found no eligible studies for this question.

1 finding from 1 review

Manually‐generated reminders delivered on paper: effects on professional practice and patient outcomes 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Manual paper reminders vs usual care

Changes in professional practice (continuous) · Healthcare professionals

1 finding from 1 review

Manually‐generated reminders delivered on paper: effects on professional practice and patient outcomes 2019 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 3263 participants
Low

Manual paper reminders vs usual care

Patient outcomes (continuous) · Healthcare professionals

1 finding from 1 review

Manually‐generated reminders delivered on paper: effects on professional practice and patient outcomes 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1222 participants
Very low

Manual paper reminders added to another QI intervention vs the same QI intervention

Changes in professional practice (continuous) · Healthcare professionals

1 finding from 1 review

Manually‐generated reminders delivered on paper: effects on professional practice and patient outcomes 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 12372 participants
Moderate

Lithium vs lamotrigine

Efficacy: response (continuous) change in BPRS (total) from baseline to end of study ‐all data · acute mania

1 finding from 1 review

Lithium for acute mania 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 301 participants
Moderate

Lithium vs placebo

Efficacy: response (continuous) Change in YMRS (ITT‐LOCF) from baseline to end of study · acute mania

1 finding from 1 review

Lithium for acute mania 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 935 participants
High